Notably, hsa-miR-320b was predicted to target FOXM1, with miR-320b downregulated in OSA-exo and FOXM1 upregulated in OSA-exo–treated cells, suggesting a potential regulatory axis (Fig 3f). The gene discussed is FOXM1; the disease is obstructive sleep apnea syndrome.